Clinical Trial Update: First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C [Phase 1]

View source ↗

Summary

First-in-human study of AL-704 includes single-dose food-effect in healthy volunteers and multiple-dose exposure in chronic hepatitis C; the trial status is ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• AL-704

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Chronic Hepatitits C | Phase 1 | Status: TERMINATED